Chinese scientist He Jiankui speaks at the Second International Summit on Human Genome Editing in Hong Kong on Nov. 28, 2018. The conference was upended by revelations about his work editing the genes on a set of twins.
(ANTHONY WALLACE/AFP/Getty Images)
The scientific community and the world at large are still reeling from the news that a rogue Chinese scientist conducted experiments that ultimately resulted in CRISPR-edited twin girls. The scientist's behavior may have been anomalous, but the use of CRISPR and other gene-editing technologies is something we've been tracking here at Stratfor for a number of years. The potential applications spread across a wide swath of sectors, from agriculture to industry to medicine. Much as we see a tech race on artificial intelligence between China and the United States, we expect a similar one in biotech....
To empower members to confidently understand and navigate a continuously changing and complex global environment.